(Q46844094)

English

Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

author name string

Haibo He

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Xianzhe Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Mengqiong Shi

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Xiaowei Zeng

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Jun Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Limao Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Lianda Li

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

60

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

115-123

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Two new quinochalcone yellow pigments from Carthamus tinctorius and Ca2+ antagonistic activity of tinctormine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Production of reactive oxygen species after reperfusion in vitro and in vivo: protective effect of nitric oxide

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Altered patterns of gene expression in response to myocardial infarction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1211/JPP.60.1.0015

Identifiers

10.1211/JPP.60.1.0015

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18088512

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46844094&oldid=2134500543"